News

October 3, 2025

PRISM BioLab was granted a new patent covering a novel class of bicyclic PepMetics® compounds on...

October 3, 2025

We would like to announce that PRISM BioLab and Servier have mutually agreed to terminate the...

August 2, 2025

We would like to announce that PRISM BioLab and Eli Lilly and Company have mutually agreed...

June 9, 2025

PRISM BioLab is pleased to announce that we obtained a patent for our novel compound library...

May 23, 2025

TOKYO, Japan, 23 May 2025: -- PRISM BioLab, Co. Ltd. , a leading discovery and development...

May 14, 2025

CEO Dai Takehara will participate in the "103rd IR Seminar for Individual Investors" hosted by Logmi...

May 10, 2025

Nikkei Biotech has published an interview with our CEO Dai Takehara, and our Director/Head of R&D...

April 14, 2025

PRISM BioLab has been featured in The Nikkei (Nihon Keizai Shimbun). "PRISM BioLab and AI Drug...

April 13, 2025

TOKYO, Japan, 14 April 2025 -- PRISM BioLab, Co. Ltd., a leading discovery and development biotechnology...

March 13, 2025

Our CEO, Takehara, recently appeared on Radio NIKKEI 1’s The Money – Thursday, Hideaki Sakurai’s Kabutetsu....